Scotia Capital’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Scotia Capital’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-22,439	Closed	-$1.47M	–	822
2015 Q4	$1.47M	Hold	22,439	–	–	0.03%	331
2015 Q3	$1.49M	Sell	22,439 -2,370	-10%	-$184K	0.03%	312
2015 Q2	$1.92M	Sell	24,809 -937	-4%	-$72.9K	0.04%	292
2015 Q1	$1.97M	Buy	+25,746	New	+$1.89M	0.05%	226

Other funds holding PJP

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SCM

Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

Scotia Capital's PJP Position: Q1 2016 in Review

Scotia Capital sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2016, closing a stake of 22,439 shares — an estimated $1.47M sold.

Scotia Capital first reported a position in PJP in Q1 2015 and held it in 4 quarters. The position peaked at $1.97M in Q1 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2016.

Scotia Capital reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
Scotia Capital sold 22,439 Invesco Pharmaceuticals ETF shares in Q1 2016, an estimated $1.47M.
Scotia Capital first reported a position in Invesco Pharmaceuticals ETF in Q1 2015 and held it in 4 quarters.
Scotia Capital's Invesco Pharmaceuticals ETF position peaked at $1.97M in Q1 2015.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2016.

Based on Scotia Capital's 13F filing for Q1 2016, filed 12 May 2016.